Related Experiment Video

Updated: Jun 4, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Stenting of the Left Main Coronary Artery in a Patient With Takayasu's Arteritis

Hyo Keun Lee1, June Namgung, Won-Ho Choi

  • 1Department of Internal Medicine, Vision 21 Cardiac and Vascular Center, Inje University, Ilsan Paik Hospital, Goyang, Korea.

Korean Circulation Journal
|March 2, 2011
PubMed

Insights

Takayasu

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Rheumatology

Background:

  • Takayasu's arteritis (TA) poses management challenges for left main coronary artery (LMCA) stenosis due to high restenosis rates.
  • Endovascular interventions like stenting and angioplasty are frequently reported as safe and effective for TA-related LMCA stenosis.
  • Recurrent in-stent restenosis in TA necessitates exploring alternative treatment strategies beyond repeat endovascular procedures.

Purpose of the Study:

  • To present a case of recurrent in-stent restenosis in the left main coronary artery (LMCA) due to Takayasu's arteritis.
  • To highlight the limitations of repeated percutaneous coronary interventions in managing complex LMCA stenosis in Takayasu's arteritis.
  • To emphasize the consideration of coronary artery bypass graft (CABG) surgery as a definitive treatment option.

Main Methods:

  • Case report detailing the clinical course of a patient with Takayasu's arteritis affecting the LMCA.
  • Documentation of two sequential percutaneous coronary interventions (PCI) for recurrent in-stent restenosis.
  • Surgical intervention with coronary artery bypass graft (CABG) for myocardial infarction secondary to LMCA stenosis.

Main Results:

  • The patient experienced recurrent in-stent restenosis after two successful PCIs for LMCA stenosis.
  • Myocardial infarction occurred despite repeat endovascular interventions, indicating treatment failure.
  • Coronary artery bypass graft (CABG) surgery was ultimately performed due to the persistent and severe nature of the LMCA stenosis.

Conclusions:

  • Coronary artery bypass graft (CABG) surgery may be a more suitable definitive treatment for left main coronary artery (LMCA) stenosis in Takayasu's arteritis.
  • The distinct pathophysiology of Takayasu's arteritis compared to atherosclerotic stenosis warrants tailored therapeutic approaches.
  • Recurrent restenosis after endovascular treatment suggests the need for surgical consideration in select cases of Takayasu's arteritis.

Keywords:
Coronary artery diseasePercutaneous transluminal coronary angioplastyTakayasu arteritis

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...